Preventing cervical cancer through quick self-sampling and testing
Official title: PROGRESS: PRevention of cervical cancer using the Genotyping scREening and Same-day Self-sampling
Funded at Atila Biosystems, INC. · NIH-10696230 · Data updated 2026-11-12
This study is testing a new, easy, and affordable way for women to check for high-risk HPV, which can lead to cervical cancer, so they can get quick results and same-day treatment, especially in places where cervical cancer is more common.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Atila Biosystems, INC. NIH-funded |
| Lab location | 1 site (Sunnyvale, UNITED STATES) |
| Project start | September 5, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $986,359 |
| NIH project number | 5R44CA272177-02 |
| Project ID | NIH-10696230 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include women, particularly adolescents and young adults, who are at risk for cervical cancer and live in low- and middle-income countries.
✕Less likely to help
Patients who are not at risk for cervical cancer or those who have already been diagnosed and treated for the disease may not benefit from this research.
What this research studies
This research focuses on developing a low-cost, efficient method for cervical cancer prevention by utilizing a new HPV self-sampling test. The modified AmpFire® HPV Genotyping test allows for rapid identification of high-risk HPV types and provides immediate results, enabling same-day treatment for women at high risk of developing cervical cancer. By streamlining the screening process, the research aims to improve access to care, particularly in low- and middle-income countries where cervical cancer rates are highest.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence and mortality of cervical cancer by facilitating timely diagnosis and treatment.
How similar studies have gone: Other research has shown promise in using self-sampling and rapid testing for HPV, indicating that this approach could be effective in improving cervical cancer screening and treatment.
Where this research is happening
-
Atila Biosystems, INC.
Sunnyvale, United States Active
Researchers
- Principal investigator: Wang, Youxiang — Atila Biosystems, INC.
- Study coordinator: Wang, Youxiang
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.